NASDAQ:HBIO - Nasdaq - US4169061052 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 97.73M | 112.25M | 113.30M | 118.90M | 102.10M | |||
Cost Of Goods | 40.65M | 45.86M | 51.00M | 51.30M | 44.10M | |||
Gross Profit | 57.08M | 66.39M | 62.30M | 67.70M | 58.00M | |||
Operating Expenses | 62.44M | 64.11M | 67.10M | 64.20M | 57.80M | |||
Research and Development | 11.23M | 11.76M | 12.30M | 10.80M | 8.70M | |||
Selling, General, and Administrative Expenses | 45.01M | 46.82M | 48.60M | 47.70M | 43.40M | |||
Operating Income | -5.37M | 2.29M | -4.70M | 3.40M | 200.00K | |||
Interest Income/Expense | -5.00M | -4.22M | -2.50M | -1.50M | -4.80M | |||
Other Income/Expense | -1.17M | -227.00K | 300.00K | -700.00K | -800.00K | |||
Non Recurring Items | N/A | -391.00K | -2.20M | -1.30M | -1.90M | |||
Income Before Taxes | -13.36M | -2.56M | -9.20M | -100.00K | -7.30M | |||
Income Tax | 883.00K | 859.00K | 300.00K | 100.00K | 500.00K | |||
Net Income | -14.24M | -3.42M | -9.50M | -300.00K | -7.80M | |||
EBITDA | 1.81M | 9.28M | 2.87M | 11.02M | 7.83M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.33 | -0.08 | -0.23 | -0.01 | -0.20 | |||
Non GAAP EPS | 0.04 | 0.15 | 0.12 | 0.25 | 0.16 | |||
Statistics | ||||||||
Gross Profit Margin | 58.40% | 59.15% | 54.99% | 56.94% | 56.81% | |||
Profit Margin | -14.57% | -3.04% | -8.38% | -0.25% | -7.64% | |||
Operating Profit Margin | -5.49% | 2.04% | -4.15% | 2.86% | 0.20% |
All data in USD